TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
To no one’s surprise, the U.S. government, after hysterically declaring a “national emergency” over America’s opioid crisis, is once again setting its sights on kratom, the non-addictive natural plant that has helped thousands of Americans wean themselves off opioids. In 2015, the DEA announced its plans to place kratom on the list of Controlled Substances (in Read More…
The Food and Drug Administration has just approved a new pill with a digital sensor in it. It will “ensure” that patients who suffer from mental health issues take their medicine when they are told. But privacy concerns have not gone unnoticed. Regulators in the United States have approved the first pill that can be digitally tracked Read More…
Many of the chemical products still in use today were deemed “safe” by EPA based on studies the agency knew were fraudulent and dangerous. (TFTP) Secrecy, collusion, deception, cover-up, concealment. These are some of the words used in a bombshell report to describe how the Environmental Protection Agency (EPA) and other federal regulators sacrificed human and environmental Read More…
If you’re hurt by a pharmaceutical, you can sue the company that made the drug, and be compensated for your losses, right? Most people assume that is the way the justice system works, but the reality is that it’s difficult, and in many cases impossible, for victims of pharmaceutical companies (and other big corporations/industries) to Read More…
Government funding cuts seem to be the one overarching plot line tying the Trump Administration narrative together. We’ve seen this in the fiscal budget cuts and now in the most recent reveal of the Senate healthcare bill that could leave 22 million people without health insurance. Throughout this narrative, the media has done an influential Read More…
One-third of FDA-approved drugs were later found to have safety risks, according to a recent analysis of drugs cleared by the agency between 2001 and 2010. According to the study, published in the Journal of the American Medical Association, “Among 222 novel therapeutics approved by the FDA from 2001 through 2010, 71 (32.0%) were affected Read More…